Ultra-Sensitive Duplex Sequencing for Quantifying Multi-Individual Cell Therapy Sub-Population Fractions - TwinStrand Biosciences

Skip to content

NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

Technology
Products
- AML Assay
Resources
- Publications
- Posters
- Safety
- Patents
Company
- Our Team
- News
- Investors

Technology
Products
- AML Assay
Resources
- Publications
- Posters
- Safety
- Patents
Company
- Our Team
- News
- Investors

Ultra-Sensitive Duplex Sequencing for Quantifying Multi-Individual Cell Therapy Sub-Population Fractions

For Research Use Only. Not for use in diagnostic procedures.

©2026 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices